Medicinal Chemistry, Drug Discovery & Drug Delivery

Nanomedicine & Fullerene Chemistry

Submit Abstract Register Now

Progress in nanomedicine resulted in numerous scientific papers, studies, and several promising clinical trials, but only a few clinically-approved nanodrugs. There is a growing sentiment in the field that we can do more than that. I​n order to increase the availability of nanodrugs for patients, we need to address the biological, pathophysiological, immunological and manufacturing/regulatory barriers to effective translation into the clinic.

The goals of the two day Mechanisms and Barriers in Nanomedicine workshop are to:

• Provide an educational forum on the barriers to nanoparticle translation;
• Provide a paradigm shift to overcome these problems; and
• Allow for open discussion among faculty, postdocs and graduate students, to trigger new ideas and concepts.

The workshop will consist of informal, non-concurrent sessions, followed by discussion. Talks will focus on mechanisms, problems, and solutions of the following aspects of nanomedicine:

• Bio-nano interface, immune recognition, and toxicity
• Complement
• ​In vitro and in vivo barriers
• ​No-engineering and design
• ​Metastatic cells, stem cells, and relevance of mouse models
• Regulatory/industrial hurdles